Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelius Engelmann

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2025
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular CarcinomaFabian Artusa, Sven Lamatsch, Minh Duc Phan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2025
Chronic kidney disease does not influence response to terlipressin in hepatorenal syndrome - acute kidney injuryFrank Erhard Uschner, Eva Maria Schleicher, Moritz Passenberg, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Science Advances|October 25, 2024
p53 terminates the regenerative fetal-like state after colitis-associated injuryKimberly Hartl, Şafak Bayram, Alexandra Wetzel, et al.
Annals of Transplantation|November 14, 2018
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin ProphylaxisSusanne Beckebaum, Kerstin Herzer, Artur Bauhofer, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Science Advances|March 7, 2025
Hyperammonemia induces programmed liver cell deathAnnarein J C Kerbert, Cornelius Engelmann, Abeba Habtesion, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2016
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosisAndrea De Gottardi, Jonel Trebicka, Christoph Klinger, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Liver International : Official Journal of the International Association for the Study of the Liver|May 3, 2025
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular CarcinomaFabian Artusa, Sven Lamatsch, Minh Duc Phan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2025
Chronic kidney disease does not influence response to terlipressin in hepatorenal syndrome - acute kidney injuryFrank Erhard Uschner, Eva Maria Schleicher, Moritz Passenberg, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Plos One|June 7, 2018
Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationJulia M Grottenthaler, Christoph R Werner, Martina Steurer, et al.
Science Advances|October 25, 2024
p53 terminates the regenerative fetal-like state after colitis-associated injuryKimberly Hartl, Şafak Bayram, Alexandra Wetzel, et al.
Annals of Transplantation|November 14, 2018
Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin ProphylaxisSusanne Beckebaum, Kerstin Herzer, Artur Bauhofer, et al.
Alimentary Pharmacology & Therapeutics|June 8, 2020
A prospective, multicentre study in acute non-cirrhotic, non-malignant portal vein thrombosis: comparison of medical and interventional treatmentMartin Rössle, Dominik Bettinger, Jonel Trebicka, et al.
Science Advances|March 7, 2025
Hyperammonemia induces programmed liver cell deathAnnarein J C Kerbert, Cornelius Engelmann, Abeba Habtesion, et al.
Hepatology International|March 7, 2026
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-studyKatrin Splith, Nadja Berndt, Philipp K Haber, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2016
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosisAndrea De Gottardi, Jonel Trebicka, Christoph Klinger, et al.
Pageof 11